ISRCTN83465351已完成不适用
Carnitine in the palliative treatment of advanced pancreatic cancer (CARPAN): a prospective, randomised, placebo controlled, double blinded, multicentre trial
niversity Medicine Greifswald (Germany)0 个研究点目标入组 90 人开始时间: 2011年4月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Advanced pancreatic cancer (UICC Stage IV)
- •2. A Karnofsky Index larger than 60
- •3. Compliance
- •4. The consent to participate in the study
排除标准
- •1. Patients were excluded with a Child-Pugh classification of liver failure greater than Class B
- •2. A known second malignant tumor
- •3. Oral or parenteral supplementation with omega-3-fatty acids
- •4. Treatment with Thalidomide or Infliximab
- •5. Mental or physical disorders
研究者
相似试验
招募中
2 期
Carnitine for the treatment of autismIRCT20090117001556N136Tehran University of Medical Sciences50
已完成
不适用
The L-carnitine effect in non alcoholic fatty livernon alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT201102235893N1Gasrtoenterology Research Centre Of Imam Reza Hospital80
已完成
不适用
Carnitine supplementation as a therapy to improve insulin sensitivity in Type 2 diabetic patients with low carnitine statusNL-OMON48695Academisch Medisch Centrum62
进行中（未招募）
1 期
Carnitine supplementation in type 2 diabetic patientsEUCTR2017-003124-73-NLMaastricht University36
已完成
1 期
Action investigation of carnitine in patients with anorexia nervosaAnorexia NervosaJPRN-UMIN000012891Department of Community Psychiatric Medicine of Shiga University of Medical Science30